Literature DB >> 30825966

Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical trial in primary brain tumor patients.

Kathryn R Tringale1, Tanya Nguyen2, Naeim Bahrami3, Deborah C Marshall4, Kelly M Leyden3, Roshan Karunamuni5, Tyler M Seibert5, Mary Kay Gorman4, Michael Connor4, Jeff Burkeen4, David E Piccioni6, Nikdokht Farid7, Jona A Hattangadi-Gluth5, Carrie R McDonald8.   

Abstract

BACKGROUND AND
PURPOSE: Executive function (EF) decline is common after brain radiation therapy (RT), yet the etiology is unclear. We analyzed the association between longitudinal changes in frontal lobe white matter microstructure and decline in EF following RT in brain tumor patients on a prospective clinical trial.
MATERIALS AND METHODS: Diffusion tensor imaging was obtained on 22 patients with brain tumors prior to RT, as well as 3- and 6-months post-RT, in a prospective, observational trial. Fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) were calculated within the superficial white matter (SWM) of the anterior cingulate (AC) and dorsolateral prefrontal cortex. Measures of cognitive flexibility, verbal fluency, and verbal set-shifting were obtained pre- and post-RT. Reliable change indices were calculated to determine significant baseline to 6-month EF changes.
RESULTS: Decreases in FA and increases in MD were observed in the caudal AC (CAC) at 3-months post-RT. CAC changes were characterized by increased RD bilaterally. From baseline to 6-months post-RT, decreased FA and increased MD and RD of the CAC was associated with decline in verbal set-shifting ability, whereas increased MD in the CAC was associated with a decline in cognitive flexibility.
CONCLUSION: White matter underlying the AC may be particularly vulnerable to radiation effects. Early microstructural loss within AC SWM represents an important biomarker for EF decline, and dose reduction in this region may represent a possibility for cognitive preservation for patients receiving radiotherapy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain tumors; Executive function; Neurocognition; Neuroimaging; Radiation therapy

Mesh:

Substances:

Year:  2018        PMID: 30825966      PMCID: PMC6400307          DOI: 10.1016/j.radonc.2018.11.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial.

Authors:  Roshan Karunamuni; Kathryn R Tringale; Jeffrey Burkeen; Michelle D Tibbs; Minh-Phuong Huynh-Le; Naeim Bahrami; Deborah Marshall; Tyler M Seibert; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  J Neurooncol       Date:  2019-11-23       Impact factor: 4.130

Review 2.  Neurological side effects of radiation therapy.

Authors:  J Jacob; L Feuvret; J-M Simon; M Ribeiro; L Nichelli; C Jenny; D Ricard; D Psimaras; K Hoang-Xuan; P Maingon
Journal:  Neurol Sci       Date:  2022-02-11       Impact factor: 3.307

3.  Radiation dose to circumscribed brain regions and neurocognitive function in patients with meningioma.

Authors:  Angela Sekely; Derek S Tsang; Donald Mabbott; Paul Kongkham; Gelareh Zadeh; Konstantine K Zakzanis; Kim Edelstein
Journal:  Neurooncol Pract       Date:  2022-02-19

4.  Quantitative study of the changes in brain white matter before and after radiotherapy by applying multi-sequence MR radiomics.

Authors:  Mingming Chen; Lizhen Wang; Guanzhong Gong; Yong Yin; Pengcheng Wang
Journal:  BMC Med Imaging       Date:  2022-05-13       Impact factor: 2.795

5.  Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline.

Authors:  Mia Salans; Michelle D Tibbs; Roshan Karunamuni; Anthony Yip; Minh-Phuong Huynh-Le; Anna Christina Macari; Anny Reyes; Kathryn Tringale; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

6.  Precision Radiotherapy for Gliomas: Implementing Novel Imaging Biomarkers to Improve Outcomes With Patient-Specific Therapy.

Authors:  Michael Connor; Michelle M Kim; Yue Cao; Jona Hattangadi-Gluth
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

7.  Microstructural Injury to Corpus Callosum and Intrahemispheric White Matter Tracts Correlate With Attention and Processing Speed Decline After Brain Radiation.

Authors:  Minh-Phuong Huynh-Le; Michelle D Tibbs; Roshan Karunamuni; Mia Salans; Kathryn R Tringale; Anthony Yip; Michael Connor; Aaron B Simon; Lucas K Vitzthum; Anny Reyes; Anna Christina Macari; Vitali Moiseenko; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-01-04       Impact factor: 8.013

8.  Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases.

Authors:  Line Brennhaug Nilsen; Ingrid Digernes; Endre Grøvik; Cathrine Saxhaug; Anna Latysheva; Oliver Geier; Birger Breivik; Dag Ottar Sætre; Kari Dolven Jacobsen; Åslaug Helland; Kyrre Eeg Emblem
Journal:  Neurooncol Adv       Date:  2020-02-28

Review 9.  White Matter Tracts and Diffuse Lower-Grade Gliomas: The Pivotal Role of Myelin Plasticity in the Tumor Pathogenesis, Infiltration Patterns, Functional Consequences and Therapeutic Management.

Authors:  Hugues Duffau
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

10.  Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.

Authors:  Mia Salans; Michelle D Tibbs; Minh-Phuong Huynh-Le; Anthony Yip; Kathryn Tringale; Roshan Karunamuni; Ronghui Xu; Anny Reyes; Anna Christina Macari; Tonya Pan-Weisz; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-06-06       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.